ROCÍO
GARCÍA CARBONERO
Profesora asociada de Ciencias de la Salud
Ospedale San Martino
Génova, ItaliaPublicacions en col·laboració amb investigadors/es de Ospedale San Martino (6)
2023
-
Fruquintinib versus placebo in patients with refractory metastatic colorectal cancer (FRESCO-2): an international, multicentre, randomised, double-blind, phase 3 study
The Lancet, Vol. 402, Núm. 10395, pp. 41-53
2020
-
Neutropenia and survival outcomes in metastatic colorectal cancer patients treated with trifluridine/tipiracil in the RECOURSE and J003 trials
Annals of Oncology, Vol. 31, Núm. 1, pp. 88-95
2019
-
Exploratory findings from a prematurely closed international, multicentre, academic trial: RAVELLO, a phase III study of regorafenib versus placebo as maintenance therapy after first-line treatment in RAS wild-type metastatic colorectal cancer
ESMO Open, Vol. 4, Núm. 4
-
Regorafenib for Patients with Metastatic Colorectal Cancer Who Progressed After Standard Therapy: Results of the Large, Single-Arm, Open-Label Phase IIIb CONSIGN Study
Oncologist, Vol. 24, Núm. 2, pp. 185-192
2017
-
Proxies of quality of life in metastatic colorectal cancer: Analyses in the RECOURSE trial
ESMO Open, Vol. 2, Núm. 5
2015
-
Randomized trial of TAS-102 for refractory metastatic colorectal cancer
New England Journal of Medicine, Vol. 372, Núm. 20, pp. 1909-1919